We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN icon
126
CALL
Biohaven
BHVN
$2.17B
$3.75M 0.06%
+250,000
New +$3.64M
DKNG icon
127
PUT
DraftKings
DKNG
$11B
$3.74M 0.06%
+100,000
New +$4.43M
MOBX icon
128
Mobix Labs
MOBX
$26M
$3.71M 0.06%
459,680
+32,080
+8% +$295K
JD icon
129
JD.com
JD
$44.3B
$3.62M 0.05%
+103,400
New +$3.37M
VSXY
130
Victoria's Secret
VSXY
$7.43B
$3.26M 0.05%
120,000
-35,000
-23% -$786K
ROKU icon
131
Roku
ROKU
$22.3B
$3.17M 0.05%
31,623
+18,982
+150% +$1.75M
HSY icon
132
Hershey
HSY
$36.8B
$3.06M 0.05%
+16,338
New +$2.97M
GE icon
133
GE Aerospace
GE
$389B
$3.04M 0.05%
10,105
+8,147
+416% +$2.23M
STZ icon
134
Constellation Brands
STZ
$22.6B
$3M 0.04%
+22,278
New +$3.54M
CROX icon
135
Crocs
CROX
$6.43B
$2.8M 0.04%
33,480
+7,795
+30% +$712K
NCLH icon
136
Norwegian Cruise Line
NCLH
$8.89B
$2.76M 0.04%
+111,979
New +$2.72M
VRCA icon
137
Verrica Pharmaceuticals
VRCA
$92.1M
$2.75M 0.04%
639,193
-248,941
-28% -$1.5M
CVNA icon
138
Carvana
CVNA
$75.1B
$2.68M 0.04%
+35,550
New +$2.54M
PYPL icon
139
PayPal
PYPL
$51.1B
$2.63M 0.04%
+39,275
New +$2.77M
SYRE icon
140
Spyre Therapeutics
SYRE
$9.12B
$2.61M 0.04%
156,000
-16,000
-9% -$261K
ASML icon
141
ASML
ASML
$655B
$2.52M 0.04%
+2,600
New +$2.04M
INTC icon
142
Intel
INTC
$503B
$2.44M 0.04%
+72,800
New +$1.76M
CRBP icon
143
Corbus Pharmaceuticals
CRBP
$180M
$2.43M 0.04%
192,000
– –
TPL icon
144
Texas Pacific Land
TPL
$24.5B
$2.42M 0.04%
7,770
+6,621
+576% +$2.08M
CNDT icon
145
Conduent
CNDT
$271M
$2.34M 0.03%
836,000
– –
AROC icon
146
Archrock
AROC
$5.84B
$2.32M 0.03%
+88,070
New +$2.12M
MNST icon
147
Monster Beverage
MNST
$92.1B
$2.25M 0.03%
33,439
+29,442
+737% +$1.84M
COR icon
148
Cencora
COR
$63.2B
$2.2M 0.03%
+7,033
New +$2.07M
CLX icon
149
Clorox
CLX
$12.8B
$2.09M 0.03%
+16,923
New +$2.1M
MTDR icon
150
Matador Resources
MTDR
$6.04B
$1.97M 0.03%
+43,917
New +$2.14M
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.